The 2019 UCL Biopharmaceutical Society Conference will be held on 23 February 2019 from 10am to 4pm
The conference will be held at UCL Cruciform LT1
1. ReNeuron (Sharon Grimster)
Founded in 1997, ReNeuron is a UK-based stem cell research company with the aim to develop novel stem cell therapies that target areas of significant medical need. ReNeuron’s lead clinical candidate, a stroke therapy, is the first cell-based therapy of its kind and has already successfully passed Phase II clinical trials. Additionally, ReNeuron is developing a treatment for retinal diseases that is based on human retinal progenitor cells (hRPC), which are implanted into the retina to help prevent the deterioration of, or even, restore vision. Such exciting developments make ReNeuron a world-leading stem cell research company with the potential to change people’s lives.
2. Professor David Gems “What is ageing? Lessons from C. elegans”
Professor Gems is a geneticist and biogeronotologist, who is currently Professor of Biology and Ageing at UCL and Deputy Director of the Institute of Healthy Ageing. His work focuses on the genetics of ageing as means for understanding the overall causes of ageing and age-related diseases, placing him at the forefront of the field. His nematode models of ageing have also provided great insight into what exactly ageing is and how we may one day prevent it.
3. Dr Lynn Cox
Professor Lynne Cox is an associate professor from the University of Oxford who studies the molecular basis of ageing. Her research team is following up their pathway discovery with targeted intervention using pharmacological agents to delay or inhibit senescence, or even reverse detrimental phenotypes. Lynne Cox aims to develop ways of altering the rate of onset or outcomes of cell senescence, in order to better treat age-associated diseases and frailty. She will be telling us more about her research on the mechanisms associated with cellular senescence like DNA damage, activation of oncogenes and telomere shortening – some the causes that underlie organismal ageing and frailty.
4. Dr Nazif Alic
Dr Nazif Alic is a Senior Research Associate at UCL Institute of Healthy Ageing. He is interested in how transcriptional changes drive the plasticity of adult physiology, and how manipulation metabolism can affect lifespan. The aim of his research is to increase the period when we are healthy, rather than our lifespan. In his talk he will present a piece of research that he has recently completed with a team “Inhibition of RNA polymerase III mediates the effects of rapamycin on fruitfly lifespan.
5. Professor Stephen Harridge
We will be releasing the detailed programme outline soon!
Tickets are free for members! Get your tickets through the exclusive link that has been sent to all paying members’ emails.
Non-members and the public may purchase tickets for £3 by clicking here!